The Company's intellectual property portfolio now contains over 575 issued patents and pending patent applications covering compositions of matter and methods of use for Idera's technologies that include TLR-targeted immune modulatory oligonucleotides (IMO), gene silencing oligonucleotide (GSO) technology, and antisense technology.
What does IMO stand for?
IMO stands for Immune Modulatory Oligonucleotides
This definition appears somewhat frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of IMO
We have 127 other meanings of IMO in our Acronym Attic
- Institute of Management, Nirma University (Ahmedabad, India)
- In My Not-Very-Humble Opinion
- Internet Marketers of New York
- Independent Music New Zealand
- I Mean Obviously
- I'm Moving On
- Icelandic Meteorological Office
- Idaho Mounted Orienteering (club)
- Im Moment (German: In This Moment)
- Imaobong Missionary Outreach
Samples in periodicals archive:
Nasdaq: IDRA) today announced the issuance of patents covering compositions and methods of using its synthetic immune modulatory oligonucleotides targeted to Toll-like receptors (TLRs).
Immune Modulatory Oligonucleotides (IMO([R])) This portfolio holds over 280 patents and patent applications worldwide covering Idera's IMO technologies, which includes claims covering novel agonists of Toll-like Receptors (TLRs) 7, 8 and 9 and antagonists of TLRs 7 and 9.
The granting of patents in Europe and Australia in the field of Immune Modulatory Oligonucleotides (IMOs) that target TLRs.
AMEX: IDP) today announced the granting of patents in Europe (EU 1,278,761) and Australia (AU 2001257366) on immune modulatory oligonucleotides (IMO(TM)) that target Toll-like Receptors (TLRs).